Loading company…
Sanyan Bio develops extracellular matrix materials for medical aesthetics and health applications.
Founded in 2022, Sanyan Bio develops extracellular matrix efficacy materials using protein expression and AI-assisted design. Its products include recombinant human elastin, fibronectin and Cu/Zn-SOD, as well as sodium hyaluronate. The company is based in Hangzhou, China. In April 2026, it raised over CNY 10 million in Series A funding led by CCB International to expand production, upgrade its technology platform and advance product research and registration.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in